Henri Termeer News
Most Popular Henri Termeer Story
Genzyme: CEO compensation down 25%
Bad news for Genzyme CEO Henri Termeer (photo): The company has declined to give him a bonus this year, citing manufacturing woes at the Allston Landing plant. His total compensation came in at 25... Read more...
Latest Headlines
- March 12, 2010
- February 22, 2010
- January 22, 2010
- January 8, 2010
- December 18, 2009
- November 20, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
